425: Strive & Semler Scientific Merger: Risks & Next Steps

Strive, Inc. and Semler Scientific, Inc. announce a proposed business combination, detailing associated risks and procedural requirements for the merger.

Summary

• This Form 425 filing pertains to the proposed business combination between Strive, Inc. and Semler Scientific, Inc.
• The communication was posted on X.com by Strive's Chief Executive Officer, Matthew Cole, and Chief Financial Officer, Ben Pham, on September 22, 2025.
• The filing includes a cautionary statement regarding forward-looking statements, outlining various risks and uncertainties associated with the proposed transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the merger.
• The Registration Statement will incorporate an Information Statement/Proxy Statement/Prospectus, which will be sent to Semler Scientific stockholders for approval of the proposed transaction.
• The document clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy any securities.

Sentiment

Score: 6

Explanation: The filing announces a proposed business combination, which is generally a positive strategic move. However, it is heavily weighted with cautionary statements and a comprehensive list of risks, balancing the overall sentiment towards neutral-to-slightly positive, acknowledging the strategic intent while highlighting potential challenges.

Positives

• The proposed transaction is anticipated to bring strategic and financial benefits to the combined company.
• Expected outcomes include anticipated cost savings and strategic gains from the business combination.

Negatives

• The proposed transaction may not close as expected or at all if conditions to closing are not met or satisfied in a timely manner.
• Anticipated benefits, including cost savings and strategic gains, may not be fully realized or may not occur when expected.
• The integration of the two companies could prove more difficult, time-consuming, or costly than initially projected.
• The completion of the proposed transaction may be more expensive or take longer than anticipated due to unforeseen factors or events.
• Management's attention may be diverted from ongoing business operations and other opportunities during the merger process.
• The issuance of additional shares of Strive's Class A common stock in connection with the transaction could lead to dilution for existing shareholders.
• There is a potential for adverse reactions from Strive's or Semler Scientific's customers, or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement by either Strive or Semler Scientific.
• The possibility that the proposed transaction does not close when expected or at all due to conditions to closing not being received or satisfied.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The risk that anticipated benefits, including cost savings and strategic gains, are not realized as expected, potentially due to changes in Bitcoin treasury strategies, general economic conditions, interest/exchange rates, monetary policy, and regulatory enforcement.
• Challenges in integrating the two companies, which may be more difficult, time-consuming, or costly than anticipated.
• The proposed transaction potentially being more expensive or taking longer to complete than expected.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before the closing of the transaction.
• Risks associated with Bitcoin and other digital assets, particularly concerning the implementation of Bitcoin treasury strategies.

Future Outlook

The proposed transaction is expected to result in strategic and financial benefits, including anticipated cost savings and strategic gains for the combined company. However, these forward-looking statements are subject to significant risks and uncertainties, including the ability to successfully integrate businesses and manage Bitcoin treasury strategies, which could cause actual results to differ materially from expectations.

Management Comments

• Strive's CEO and CFO posted this communication, which includes a cautionary statement regarding forward-looking statements, emphasizing inherent risks and uncertainties in the proposed transaction and future financial performance.

Industry Context

This filing is a standard procedural and risk disclosure for a proposed merger between Strive, Inc. and Semler Scientific, Inc. The mention of 'Bitcoin treasury strategies' suggests that the combined entity may have exposure to or strategic interests in digital assets, aligning with a broader trend of corporate adoption of cryptocurrencies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company is identified as a potential risk factor for the proposed transaction.

Stakeholder Impact

• Potential adverse reactions from Strive's or Semler Scientific's customers could impact business relationships.
• Changes to business or employee relationships may occur as a result of the announcement or completion of the proposed transaction.
• Existing shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific, Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Stockholder Approval, Bitcoin Treasury Strategies